Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	52	33	27	33	69	44
Market Cap Growth	130.83%	24.62%	-17.94%	-52.77%	55.54%	-43.35%
Enterprise Value	46	37	27	31	59	37
Last Close Price	3.44	2.37	1.79	2.25	4.67	2.95
PS Ratio	1.18	0.88	0.68	0.78	1.92	1.18
PB Ratio	1.84	1.48	0.91	0.91	1.62	0.95
P/TBV Ratio	4.64	8.39	4.39	6.84	3.83	2.46
P/FCF Ratio	7.32	-	4.59	3.90	11.04	8.40
P/OCF Ratio	7.23	-	4.38	3.85	10.86	8.18
PEG Ratio	-	1.52	1.52	1.52	1.52	1.52
EV/Sales Ratio	1.09	0.98	0.67	0.73	1.65	0.99
EV/EBITDA Ratio	27.12	-	-	-	-	-
EV/FCF Ratio	6.50	-	4.56	3.67	9.49	6.99
Debt / Equity Ratio	0.37	0.91	0.63	0.58	0.38	0.36
Debt / EBITDA Ratio	2.86	50.39	32.10	15.97	-	-
Debt / FCF Ratio	1.47	-	3.17	2.51	2.57	3.24
Asset Turnover	0.57	0.48	0.45	0.47	0.40	0.37
Inventory Turnover	1.79	1.53	0.84	1.00	0.92	0.89
Quick Ratio	1.10	0.94	1.00	1.15	1.76	1.45
Current Ratio	1.30	1.15	1.28	1.61	2.37	1.95
Return on Equity (ROE)	-10.89%	-24.88%	-19.41%	-14.38%	-12.51%	-13.53%
Return on Assets (ROA)	-2.55%	-5.11%	-4.44%	-4.02%	-5.30%	-3.97%
Return on Capital (ROIC)	-4.37%	-8.85%	-7.42%	-6.17%	-7.83%	-5.84%
Earnings Yield	-5.70%	-19.47%	-23.51%	-17.12%	-5.09%	-7.54%
FCF Yield	13.66%	-2.04%	21.77%	25.66%	9.05%	11.91%
Buyback Yield / Dilution	-2.24%	1.67%	1.82%	2.29%	1.70%	1.52%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q